Presenters
Professor and Chair of Internal Medicine
Prof. Per-Henrik Groop, MD, DMSc, FRCPE
Course Details
The aim of this webinar is to provide updates Type 2 Diabetes management and how Linagliptin has brought improvements in diabetes care over the last 10 years. It will discuss the clinical trials of linagliptin – its efficacy, cardiovascular and renal safety and convenience across a broad range of T2D patients, and how it helps make the management of a complex disease more simple.
CPD Points: 1 Point
PRC Program No: PROG-2021-20660
A decade of Simplicity Experience in T2D management: Why it matters? Course Outline
- How did Linagliptin improve Type 2 Diabetes care in the last 10 years?
- Efficacy and convenience of Linagliptin in T2D patients
- CARMELINA and CAROLINA: an Extensive Dataset from a Unique CVOT program
- Can a broad range of T2D patients benefit from the Simplicity of Linagliptin
- Course Evaluation
PC-PH-103825 / March 2023